Advertisement

Index by author

September 01, 2013; Volume 41,Issue 9

  1. Gogliotti, Rocco D.

    1. Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084

  2. Graf, Tyler N.

    1. A Systematic Approach to Evaluate Herb-Drug Interaction Mechanisms: Investigation of Milk Thistle Extracts and Eight Isolated Constituents as CYP3A Inhibitors
      Scott J. Brantley, Tyler N. Graf, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2013, 41 (9) 1662-1670; DOI: https://doi.org/10.1124/dmd.113.052563

  3. Gschwind, Hans-Peter

    1. Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716

  4. Hadden, Chad E.

    1. The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094

  5. Hall, Stephen D.

    1. The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094

  6. Han, Xu

    1. Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506

  7. Jin, Yi

    1. Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716

  8. Johansson, Maria

    1. Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698

  9. Jones, Carrie K.

    1. Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084

  10. Kearns, Gregory L.

    1. The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity (Low Km) Catalyst
      Robin E. Pearce, Michael Cohen-Wolkowiez, Mario R. Sampson and Gregory L. Kearns
      Drug Metabolism and Disposition September 2013, 41 (9) 1686-1694; DOI: https://doi.org/10.1124/dmd.113.052548
« Previous (Pages : 1 2 3 4 5 6 7 8 9 ... 11) Next »
Back to top

In this issue

Advertisement